Cargando…
Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers
BACKGROUND: Blood biomarkers of neurovascular damage are used clinically to diagnose the presence severity or absence of neurological diseases, but data interpretation is confounded by a limited understanding of their dependence on variables other than the disease condition itself. These include hal...
Autores principales: | Dadas, Aaron, Washington, Jolewis, Marchi, Nicola, Janigro, Damir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402680/ https://www.ncbi.nlm.nih.gov/pubmed/27903281 http://dx.doi.org/10.1186/s12987-016-0045-y |
Ejemplares similares
-
Biomarkers in traumatic brain injury (TBI): a review
por: Dadas, Aaron, et al.
Publicado: (2018) -
Cerebral Waste Accumulation and Glymphatic Clearance as Mechanisms of Human Neurological Diseases
por: Dadas, Aaron, et al.
Publicado: (2016) -
Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
por: Janigro, Damir, et al.
Publicado: (2020) -
The role and diagnostic significance of cellular barriers after concussive head trauma
por: Dadas, Aaron, et al.
Publicado: (2018) -
Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
por: Janigro, Damir, et al.
Publicado: (2021)